Byetta
strong$700-$850/mo cash price
Same molecule, twice-daily dosing instead of weekly.
Adherence burden is higher; rarely preferred over the once-weekly form.
View Byetta on GLP1ZoomAlternatives
Bydureon BCise alternatives — what to ask your prescriber
A printable summary of therapeutic alternatives to Bydureon BCise (exenatide extended-release), the current FDA generic-status outlook, and the questions to bring to your prescriber visit.
These are therapeutic alternatives, NOT FDA-approved generic substitutes. Therapeutic alternatives are different medications in a similar drug class. A true generic requires FDA ANDA approval — and as of 2026, only liraglutide (Victoza / Saxenda) has an FDA-approved generic among GLP-1 medications. Only your prescriber can recommend or approve a switch.
Generic Bydureon BCise: not available until ~~2029-2031
Active ingredient
exenatide extended-release
FDA generic status
Not yet approved
Patent / NDA holder
AstraZeneca
Estimated generic year
~2029-2031
Bydureon BCise uses the ABLE microsphere autoinjector — formulation patents extend well past the underlying exenatide molecule patents. Bydureon BCise was discontinued in 2024.
Therapeutic alternatives, by category
Equivalence strength reflects shared mechanism of action plus the depth of head-to-head clinical evidence. Costs are US cash-price estimates and vary widely by pharmacy, insurance, and manufacturer copay programs.
Same drug class, different molecule
Ozempic
strong$935-$1,000/mo cash price
Newer once-weekly GLP-1 — stronger outcomes in head-to-head SUSTAIN-7 data vs exenatide.
Common upgrade path when coverage permits.
View Ozempic on GLP1ZoomTrulicity
moderate$945-$985/mo cash price
Once-weekly dulaglutide with single-use pen and CV-outcome label.
Simpler injection device than the ABLE microsphere autoinjector.
View Trulicity on GLP1Zoom
FDA-approved generic liraglutide
Non-pharmaceutical / lifestyle
Structured lifestyle + RD-supervised nutrition
weak$0-$250/mo cash price
No medication side-effect risk. Average weight loss with intensive lifestyle programs is 5-10% of body weight over 12 months — meaningful for some patients, well below GLP-1 efficacy for others.
Often combined with — not replacing — GLP-1 therapy; insurance may cover RD visits under obesity-care benefits.
Talk to a prescriber
Bring this summary to a visit, or connect with a telehealth GLP-1 prescriber who can review your insurance, dosing history, and tolerability before recommending any switch.
FAQ
- Is there a generic version of Bydureon BCise?
- No. There is no FDA-approved generic exenatide extended-release as of 2026. Bydureon BCise uses the ABLE microsphere autoinjector — formulation patents extend well past the underlying exenatide molecule patents. Bydureon BCise was discontinued in 2024.
- When will generic Bydureon BCise be available?
- Estimated US generic availability: ~2029-2031. This is an estimate based on USPTO Orange Book exclusivity and composition-of-matter patent expiry. Bydureon BCise uses the ABLE microsphere autoinjector — formulation patents extend well past the underlying exenatide molecule patents. Bydureon BCise was discontinued in 2024.
- Is compounded exenatide extended-release the same as a generic?
- No. Compounded products are prepared by licensed compounding pharmacies and are NOT FDA-approved as finished drugs. They have not undergone FDA bioequivalence testing and are not legally substitutable the way a true ANDA-approved generic would be.
- Can I switch from Bydureon BCise to one of these alternatives on my own?
- No. Switching GLP-1 medications requires a prescriber's clinical judgment about your indication, dose-titration history, side-effect tolerance, and insurance coverage. The alternatives listed here are options to DISCUSS with your prescriber — not recommendations.
Compare GLP-1 telehealth providers
SponsoredPartner offers first — we earn a commission from those — then ranked by our editorial score. Visit a partner to check current pricing and eligibility — we compare providers, we never sell medications.
Advertising disclosure: we may earn a commission if you sign up through these links, at no extra cost to you — it never affects our rankings. How we make money
- Sesame Care· from $208/moTop ratedTelehealth · online visit
- SkinnyRx· from $199/moCompounded not offered in AL, LA, MS — check before startingTelehealth · online visitCompounded · not FDA-approved
- Enhance MD· price shown after their intakeNo lab work to startRestricted in AL, AR, GA, HI, LA, MS, MO, ND, SC, TN, WV — check before startingTelehealth · online visitCompounded · not FDA-approved
- HealthRX· from $165/moLowest starting priceon the 12-month plan, $1,188 billed upfrontTelehealth · online visitCompounded · not FDA-approved